PGxome Health Screen is intended for healthy patients who want to learn their carrier status for recessive disorders and/or their susceptibility to adult onset conditions. Unlike common carrier screening tests, we sequence the full gene rather than limiting analysis to common disease causing variants within each gene. PreventionGenetics identifies and interprets all sequence variants (differences between the patient's sequence and the reference sequence) but only reports Pathogenic and Likely Pathogenic variants, meaning they are expected, with a high degree of certainty, to be disease causing.
What sets PreventionGenetics' PGxome tests apart is distributed variant interpretation. "Clinically relevant genes and their variants are interpreted by MD and PhD Geneticists who have specialization and expertise in specific disease categories," said Weber. "Our specialty-focused approach harnesses the collective knowledge and experience of many Geneticists in collaboration, and through the power of many, we are able to accurately interpret the patient's results."
Pharmacogenomic testing will soon be added to PreventionGenetics' PGxome test menu.
Founded in 2004, PreventionGenetics is a CAP, CLIA and ISO 15189-accredited clinical DNA testing laboratory, providing testing for thousands of genetic conditions. PreventionGenetics has the largest DNA test menu in America which includes single gene or panel testing for all clinically relevant genes.
PreventionGenetics also offers DNA Banking (PGDNABank), a long-term storage of a person's DNA. DNA Banking is available direct-to-consumer. We invite you to visit our DNA Banking website, PGDNABank.com.
Contact: Marsha Bushman, MBA
Business Development Officer
P: 715.387.0484 Ext. 282
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/preventiongenetics-launches-cutting-edge-genetic-test-benefiting-reproductive-and-healthy-patients-300407200.html